Unzyme Proving Grounds Beta
[REDACTED], Finland
Overview
UPG Beta was constructed incorporating lessons learned from our Alpha facility. Enhanced containment systems and redundant security measures were implemented from initial construction. Despite these precautions, certain experimental subjects demonstrated unexpected adaptive capabilities.
Capabilities
- Biological enhancement trials
- Regenerative tissue testing
- Cross-species integration studies
- Pharmaceutical compound field evaluation
Facility Status
UPG Beta remains under active quarantine. Autonomous monitoring systems continue to report activity within the containment zone. Entry is strictly prohibited without Level 5 clearance and specialized protective equipment.
Ongoing Situation
Recurring events within the quarantine perimeter are being monitored. The situation is considered stable but dynamic. Unzyme Laboratories maintains continuous surveillance and has contingency protocols in place.
Regulatory Compliance
All incidents at UPG Beta have been reported to relevant authorities in accordance with applicable regulations. The economic contributions of Unzyme Laboratories to the region have facilitated collaborative approaches to containment management.
Notable Incidents
Unexpected subject evolution observed. Containment maintained.
Recurring outbreak event #1. External perimeter secured.
Recurring outbreak event #3. Quarantine protocols activated.
Final evacuation. Facility sealed indefinitely.